Tamper Evident Packaging Market Forecasts to 2030 - Global Analysis By Product, Material, Application, End User and By Geography

According to Stratistics MRC, the Global Tamper Evident Packaging Market is accounted for $1.78 billion in 2023 and is expected to reach $3.84 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Tamper-evident packaging ensures the integrity of pharmaceuticals and medical products by providing visible signs of interference or tampering. It plays a critical role in safeguarding patient safety and maintaining the efficacy of medications. Utilizing features like seals, labels, and closures that are designed to break or show evidence of tampering upon opening, tamper-evident packaging instills confidence in consumers and healthcare professionals.

According to the Indian Institute of Packaging (IIP), packaging consumption in India has surged by 200% over the last decade, from 4.3 kilograms per person per annum (pppa) in FY10 to 8.6 kg pppa in FY20.

Market Dynamics:

Driver:

Rising incidents of counterfeiting

With the rise in counterfeit drugs and medical products, tamper-evident packaging provides a crucial layer of security, assuring consumers and healthcare professionals of the product's integrity. The tamper-resistant features help prevent unauthorized access and tampering during the product's distribution and storage, safeguarding the health and well-being of patients. As a result, the healthcare industry is increasingly embracing tamper-evident packaging solutions to combat the growing threat of counterfeit pharmaceuticals.

Restraint:

Compatibility issues

The diverse range of pharmaceutical products often requires tailored packaging solutions. Achieving compatibility between tamper-evident features and various packaging materials, sizes, and forms can be challenging. Striking a balance between effective tamper resistances and accommodating different product specifications becomes a hurdle. This complexity can result in increased production costs and hinder seamless integration into existing pharmaceutical manufacturing processes.

Opportunity:

Growing awareness & concern for product safety

As consumers become increasingly vigilant about the authenticity and integrity of pharmaceuticals and medical products, tamper-evident packaging serves as a crucial solution. It helps build trust by providing visible evidence of any interference or tampering, assuring consumers of product integrity. This heightened focus on safety aligns with the healthcare sector's commitment to maintaining the highest standards, making tamper-evident packaging a key strategy to address and capitalize on the increasing demand for secure and trustworthy healthcare products.

Threat:

Cost considerations

Implementing tamper-evident packaging solutions often involves additional expenses for materials, technology, and compliance with stringent regulations. The need for innovative seals, holographic labels, or other security measures increases production costs. The healthcare industry's budget constraints may deter widespread adoption, limiting access to tamper-proof packaging for some stakeholders. Additionally, implementing tamper-evident technologies requires investment in research and development to stay ahead of counterfeiters which further impedes the market expansion.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the market. With heightened awareness of hygiene and safety, there is an increased demand for tamper-evident solutions in pharmaceutical and medical packaging to ensure product integrity. The pandemic has accelerated the adoption of tamper-proof packaging to prevent contamination and unauthorized access to medical supplies. This has led to a surge in investments and innovations in tamper-evident technologies, reshaping the healthcare packaging landscape to meet the evolving safety concerns in the industry.

The prescription drugs segment is expected to be the largest during the forecast period

The prescription drugs segment is estimated to have a lucrative growth. Employing various seals and features, this packaging ensures the integrity of pharmaceutical products. By visibly indicating any interference or opening attempts, tamper-evident packaging provides consumers and healthcare professionals with confidence in the authenticity and safety of the medication. This preventive measure helps mitigate the risk of contamination, substitution, or unauthorized access to prescription drugs, reinforcing regulatory compliance and promoting patient trust in the pharmaceutical supply chain.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical companies segment is anticipated to witness the highest CAGR growth during the forecast period. Tamper-evident packaging plays a crucial role in pharmaceutical companies to ensure the safety and integrity of medical products. It involves incorporating features that reveal any interference, providing visible evidence of tampering. This is paramount for preventing contamination, counterfeiting, and unauthorized access to medications. It also protects consumers by guaranteeing the authenticity and safety of medications, promoting overall public health and regulatory compliance.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the escalating concerns about counterfeit drugs and medical products. Countries like India and China are particularly embracing these packaging technologies to ensure the integrity of pharmaceuticals and medical devices throughout the supply chain. It has the presence of major companies namely Amcor Limited, Mondi Group, DuPont and Sonoco. Further, stringent regulations, a growing focus on patient safety, and increasing awareness among healthcare stakeholders contribute to the expanding demand for tamper-evident packaging solutions.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to stringent regulations and the growing emphasis on patient safety. As Europe remains committed to enhancing healthcare standards, the Tamper-Evident Packaging market in the region continues to witness expansion, addressing critical concerns related to product safety and authenticity. Europe is home to several key players including Essentra Plc, Clondalkin Group and Sappi Limited. Key players are innovating with advanced technologies to offer tamper-proof solutions, positioning Europe as a pivotal region in the market.

Key players in the market:

Some of the key players profiled in the Tamper Evident Packaging Market include Schreiner Group, Avery Dennison Corporation, CCL Industries Inc, Essentra PLC, 3M Company, SCHOTT AG, Amcor Plc, DuPont de Nemours Inc, Systech International, Covectra, Ampac Holding LLC, Baker & McKenzie LLP, Dynacorp, Enercon Corporation, Berry Global Healthcare, Traco Manufacturing Inc, Interpack Limited and Seal King Europe.

Key Developments:

In April 2023, Schreiner MediPharm has launched a new product for counterfeit and tampering protection in the healthcare industry. The product utilizes void labels, which reveals covert messages upon peeling and makes it difficult for counterfeiters to reuse the original packaging.

In February 2023, Berry Global Healthcare is introducing a comprehensive bundle solution to help customers capitalise on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharmaceutical and herbal market for syrup and liquid medicines. The new Berry Healthcare bundle features seven ranges of 28mm neck PET bottles in sizes from 20ml to 1,000ml and a variety of designs, with eight accompanying closures that incorporate tamper-evident and child-resistant features.

Products Covered:

• Shrink Sleeves
• Induction Seal
• Film Wrappers
• Blister/Strip Packs
• Bubble Packs
• Other Products

Materials Covered:

• Plastic
• Glass
• Paper
• Metal
• Other Materials

Applications Covered:

• Over-The-Counter (OTC) Drugs
• Prescription Drugs
• Biologics
• Medical Devices
• Other Applications

End Users Covered:

• Pharmaceutical Companies
• Medical Device Manufacturers
• Hospitals & Clinics
• Research Institutions
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances